Navy awards $16.4M for biomedical research, with Leidos Inc. as prime contractor
Contract Overview
Contract Amount: $16,404,176 ($16.4M)
Contractor: Leidos, Inc.
Awarding Agency: Department of Defense
Start Date: 2006-09-01
End Date: 2012-08-31
Contract Duration: 2,191 days
Daily Burn Rate: $7.5K/day
Competition Type: FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Number of Offers Received: 1
Pricing Type: COST PLUS FIXED FEE
Sector: R&D
Official Description: 200612!015162!1700!N00140!FLEET AND INDUSTRIAL SUPPLY CENT!N0014006C0084 !A!N! !Y! ! !20060901!20070831!148095086!148095086!054781240!N!SCIENCE APPLICATIONS INTERNATI!10260 CAMPUS POINT DR !SAN DIEGO !CA!92121!34180!011!09!GROTON !NEW LONDON !CONN !+000000050000!N!N!000017491238!AN12!RDTE/BIOMEDICAL - APPLIED RESEARCH !S1 !SERVICES !000 !NOT DISCERNABLE !541710!E! !3! ! ! ! ! !99990909!B! ! !A! !D!U!U!1!001!N!1A!Z!Y!Z! ! !N!C!N! ! ! !A!A!A!A!000!A!B!N! ! ! ! !1718!N00140!0001! !
Place of Performance
Location: RESTON, FAIRFAX County, VIRGINIA, 20190
State: Virginia Government Spending
Plain-Language Summary
Department of Defense obligated $16.4 million to LEIDOS, INC. for work described as: 200612!015162!1700!N00140!FLEET AND INDUSTRIAL SUPPLY CENT!N0014006C0084 !A!N! !Y! ! !20060901!20070831!148095086!148095086!054781240!N!SCIENCE APPLICATIONS INTERNATI!10260 CAMPUS POINT DR !SAN DIEGO !CA!92121!34180!011!09!GROTON !NEW … Key points: 1. Contract awarded for applied biomedical research services. 2. Significant duration of over 6 years for service delivery. 3. Cost-plus-fixed-fee contract type suggests potential for cost overruns. 4. Prime contractor, Leidos Inc., has a substantial presence in federal contracting. 5. Research and Development sector, specifically biomedical applications, is a key area of federal investment. 6. Contract falls under the Department of Defense's broad R&D portfolio.
Value Assessment
Rating: fair
The awarded amount of $16.4 million for over six years of service suggests a moderate annual spend. Benchmarking this against similar biomedical research contracts is challenging without more specific details on the scope of work. The cost-plus-fixed-fee structure, while common for R&D, can lead to higher final costs than fixed-price contracts if not managed tightly. The value proposition depends heavily on the successful outcomes of the research conducted.
Cost Per Unit: N/A
Competition Analysis
Competition Level: limited
The contract was awarded under 'Full and Open Competition After Exclusion of Sources,' which implies a competitive process but with specific exclusions. The exact reasons for these exclusions are not detailed, making it difficult to assess the breadth of competition. A limited competition can sometimes result in less favorable pricing for the government compared to full and open competition.
Taxpayer Impact: The exclusion of certain sources may have limited the number of potential bidders, potentially impacting the government's ability to secure the most competitive pricing.
Public Impact
Benefits the Department of Defense by advancing biomedical research capabilities. Services delivered include applied research in biomedical fields. Geographic impact is primarily tied to the contractor's location and research facilities. Workforce implications include employment for scientists, researchers, and support staff involved in the project.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Cost-plus-fixed-fee contract type can lead to cost uncertainty.
- Limited competition may have restricted price discovery.
- Long contract duration increases exposure to changing research needs and economic conditions.
Positive Signals
- Award to a large, established contractor like Leidos Inc. suggests a degree of reliability.
- Focus on biomedical R&D aligns with critical national security and health interests.
- Contract duration allows for sustained research efforts and potential for significant breakthroughs.
Sector Analysis
This contract falls within the Research and Development sector, specifically focusing on biomedical applications. The federal government is a significant investor in R&D, particularly within defense and healthcare. The NAICS code 541710 covers Research and Development in the Physical, Engineering, and Life Sciences. Comparable spending benchmarks would require analysis of other DoD biomedical research contracts.
Small Business Impact
The contract was not set aside for small businesses, and there is no indication of subcontracting plans specifically targeting small businesses. This suggests that the primary award went to a large prime contractor, potentially limiting direct opportunities for small businesses in this specific contract vehicle.
Oversight & Accountability
Oversight would typically be managed by the Department of the Navy's contracting and program management offices. Accountability measures would be tied to the performance metrics outlined in the Cost Plus Fixed Fee contract. Transparency is generally maintained through contract award databases, but detailed project progress and financial expenditures may be less publicly accessible.
Related Government Programs
- Department of Defense Research and Development
- Biomedical Research Programs
- Naval Research Laboratory Contracts
- Science and Technology Development Contracts
Risk Flags
- Cost-plus-fixed-fee contract type can lead to cost overruns if not managed effectively.
- Limited competition may have resulted in suboptimal pricing.
- Specific research outcomes and their impact are not detailed, making value assessment difficult.
Tags
department-of-defense, department-of-the-navy, research-and-development, biomedical-research, applied-research, cost-plus-fixed-fee, definitive-contract, leidos-inc, limited-competition, science-and-technology, federal-contracting, rdte
Frequently Asked Questions
What is this federal contract paying for?
Department of Defense awarded $16.4 million to LEIDOS, INC.. 200612!015162!1700!N00140!FLEET AND INDUSTRIAL SUPPLY CENT!N0014006C0084 !A!N! !Y! ! !20060901!20070831!148095086!148095086!054781240!N!SCIENCE APPLICATIONS INTERNATI!10260 CAMPUS POINT DR !SAN DIEGO !CA!92121!34180!011!09!GROTON !NEW LONDON !CONN !+000000050000!N!N!000017491238!AN12!RDTE/BIOMEDICAL - APPLIED RESEARCH !S1 !SERVICES !000 !NOT DISCERNABLE !541710!E! !3! ! ! ! ! !999
Who is the contractor on this award?
The obligated recipient is LEIDOS, INC..
Which agency awarded this contract?
Awarding agency: Department of Defense (Department of the Navy).
What is the total obligated amount?
The obligated amount is $16.4 million.
What is the period of performance?
Start: 2006-09-01. End: 2012-08-31.
What specific biomedical research areas were prioritized under this contract?
The provided data indicates the contract was for 'RDTE/BIOMEDICAL - APPLIED RESEARCH'. However, the specific sub-disciplines or research areas within biomedical science are not detailed in the extract. Typically, applied biomedical research within the Department of Defense could encompass areas such as combat casualty care, infectious disease countermeasures, medical material development, or human performance optimization. Further investigation into the contract's statement of work or associated task orders would be necessary to identify the precise research priorities.
How does the $16.4 million contract value compare to other similar biomedical R&D contracts awarded by the Navy?
Comparing the $16.4 million contract value requires context on the duration and scope. This contract spans over six years (September 1, 2006, to August 31, 2012), making the average annual value approximately $2.7 million. This figure is moderate for large-scale R&D efforts. To provide a precise comparison, one would need to analyze a portfolio of Navy biomedical R&D contracts awarded within a similar timeframe, considering factors like research complexity, specific scientific domains, and the number of bidders. Without such a comparative analysis, it's difficult to definitively state if this represents high or low spending relative to peers.
What are the key performance indicators (KPIs) associated with this Cost Plus Fixed Fee contract?
Cost Plus Fixed Fee (CPFF) contracts, especially in R&D, typically tie performance to the achievement of specific research milestones, deliverables, and technical objectives rather than strict cost adherence, as the fee is fixed. Key performance indicators would likely include the successful completion of research phases, delivery of prototypes or data, adherence to research protocols, and timely reporting of findings. The government's contracting officer and technical monitors would assess progress against the defined Statement of Work (SOW) and any associated task orders. Failure to meet technical objectives could result in contract termination or non-payment of the fixed fee.
What is Leidos Inc.'s track record in performing similar biomedical research contracts for the federal government?
Leidos, Inc. (and its predecessor entities) has a significant and extensive track record in performing a wide array of research and development, IT, and support services for the federal government, including the Department of Defense and various health agencies. Their experience in biomedical research is substantial, often involving complex scientific challenges and large-scale projects. A detailed review of their past performance evaluations, contract history databases (like FPDS or SAM.gov), and specific project outcomes would be necessary to fully assess their capabilities and success rates in comparable biomedical R&D contracts. However, their status as a major federal contractor suggests a generally robust capability.
What was the rationale for the 'Exclusion of Sources' in this 'Full and Open Competition' award?
The designation 'Full and Open Competition After Exclusion of Sources' indicates that while the solicitation was broadly advertised, certain potential sources were intentionally excluded from consideration. The specific rationale for these exclusions is not provided in the basic data. Common reasons for such exclusions can include requirements for specific security clearances, proprietary technology access, unique capabilities possessed by only a few entities, or prior work that makes them uniquely qualified. Without further documentation (e.g., Justification for Other Than Full and Open Competition - JOFOC), the precise reasoning remains unclear, but it implies a deliberate narrowing of the competitive pool based on specific criteria.
How has federal spending on biomedical R&D evolved since this contract was awarded?
Federal spending on biomedical R&D has generally seen an upward trend since the period of this contract (2006-2012), driven by factors such as national health priorities (e.g., pandemic preparedness, cancer research), advancements in technology, and national security needs. Agencies like the National Institutes of Health (NIH) and the Department of Defense (DoD) consistently allocate significant budgets to biomedical research. While specific figures fluctuate annually based on appropriations and strategic shifts, the overall investment in this sector has remained a priority, often increasing in response to emerging threats and opportunities.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Offers Received: 1
Pricing Type: COST PLUS FIXED FEE (U)
Evaluated Preference: NONE
Contractor Details
Parent Company: Science Applications International Corporation (UEI: 078745061)
Address: 10260 CAMPUS POINT DR, SAN DIEGO, CA, 92121
Business Categories: Category Business, Not Designated a Small Business
Contract Characteristics
Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED
Cost or Pricing Data: YES
Timeline
Start Date: 2006-09-01
Current End Date: 2012-08-31
Potential End Date: 2012-08-31 00:00:00
Last Modified: 2021-07-29
More Contracts from Leidos, Inc.
- Science Operation and Maintenance Support for the United States Antarctic Program — $3.1B (National Science Foundation)
- Provide Funding for Clin 302 for Pre-Flight and In-Flight Services. Contract Number Dtfawa-05-C-00031, Lockheed Martin. POP 01/16/08-03/31/08 — $1.9B (Department of Transportation)
- THE Facilities Development and Operations Contract(fdoc) Specifies Technical, Managerial, and Adminstrative Work Needed to Ensure the Availablitity, Integrity, and Reliability of Missionoperations Facilites Supporting National Aeronautics and Space Administration (nasa) Human Space Flight (HSF) Programs Requiring Mission Operations Support. the Objective of This Contract IS to Consolidate Efforts Across the Facilities Covered Under Fodoc in Order to Maximize Synergy for Hardware and Software Development, Modification, Sustaining. Maintenance, Reconfiguration, and Operations for the Purpose of Reducing Cost Without Compromising Facility Functionality and Performance. Nasa Will Collaborate With the Contractor on Developing Procedural and Technical Innovations That Improve Quality, Ensure Customer Satisfaction and Reduce Cost. Mission Operations Facilities Currently Support the Space Shuttle Programand the International Space Station Progra, Including International Partner and Commmercial Visiting Vehicles. Mission Operations Facilities Supporting the Cnstellation Program(cxp) ARE Continuously Under Development in Concert With CXP Formulation and Implementation. Fdoc Applies to the Facilities of These Three Programs, and ANY Other HSF Program Requiring Mission Operations Facility Support. in Addition, Future Mission Operations Facilities and Capabilities ARE Within the Technical Scope of This SOW, and Fdoc Worlk Associated With These Facilities Will BE Enabled Through Idiq — $1.3B (National Aeronautics and Space Administration)
- National Airspace System (NAS) Implementation Support Contract (nisc). Provides Engineering and Technical Support Services to FAA Organizations Responsible for NAS Transformation, Integration and Implementation in the Areas of Implementation and Integration Planning, Transition Planning, Engineering Support, Environmental Support, Automation Support and Other Engineering and Technical Disciplines AS Required. TAS::69 8107::TAS — $1.1B (Department of Transportation)
- Itssc Task Order for Systems — $1.1B (Social Security Administration)
Other Department of Defense Contracts
- Federal Contract — $51.3B (Humana Government Business Inc)
- Lrip LOT 12 Advance Acquisition Contract — $35.1B (Lockheed Martin Corporation)
- SSN 802 and 803 Long Lead Time Material — $34.7B (Electric Boat Corporation)
- 200204!008532!1700!AF600 !naval AIR Systems Command !N0001902C3002 !A!N! !N! !20011026!20120430!008016958!008016958!834951691!n!lockheed Martin Corporation !lockheed Blvd !fort Worth !tx!76108!27000!439!48!fort Worth !tarrant !texas !+000026000000!n!n!018981928201!ac15!rdte/Aircraft-Eng/Manuf Develop !a1a!airframes and Spares !2ama!jast/Jsf !336411!E! !3! ! ! ! ! !99990909!B! ! !A! !a!n!r!2!002!n!1a!a!n!z! ! !N!C!N! ! ! !a!a!a!a!000!a!c!n! ! ! !Y! !N00019!0001! — $34.2B (Lockheed Martin Corporation)
- KC-X Modernization Program — $32.0B (THE Boeing Company)